BioMed Research International / 2018 / Article / Tab 3

Review Article

Prevention and Management of Complications in Laparoscopic Myomectomy

Table 3

Intraoperative bleeding during laparoscopic myomectomy without any vasoconstrive measures.

Study Myoma typePatients numberMyoma size cmMyoma multipleBleeding mlHospitalizationConversion to LMY

Sizzi et al., 2007 [11]ND2050>448NDND0.34
Tinelli et al., 2012 [15]SS + IM2354–1048118 +/− 2886% 48 hs0
Malzoni et al., 2006 [30]IM -75%9826.7 +/− 2.7473/982ND1.29
Sankaran and Odejinmi, 2013 [31]ND1257.63.7NDND1.6
Dubuisson et al., 1995 [32]IM71>5NDNDND2.7
Saccardi et al., 2014 [33]ND4448–12ND2/444ND1.35
Walid and Heaton, 2011 [16]ND412–15.6ND2–1200 mlNDND
Mallick and Odejinmi, 2017 [19]IM 49%
SS 33%
3237.7 +/− 2.84 +/− 3.6279 +/− 2211.9 +/− 0.95 days0.62
diZerega, 1997 [18]IM 34%
SS 19%
54>3ND842.09 days1.8
Mathew et al., 2013 [34]ND1,001ND44248 mL avg, 1 transf1–51 death pop unexp

Note. ND: no data.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.